Model
Edge
Revance Therapeutics Inc.
0001848717
Filing Type
4
Filing Date
5/4/2023
Updated
5/5/23, 11:14 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership